Literature DB >> 28835503

Murine Olfactory Bulb Interneurons Survive Infection with a Neurotropic Coronavirus.

D Lori Wheeler1, Jeremiah Athmer2, David K Meyerholz3, Stanley Perlman4,2.   

Abstract

Viral infection of the central nervous system (CNS) is complicated by the mostly irreplaceable nature of neurons, as the loss of neurons has the potential to result in permanent damage to brain function. However, whether neurons or other cells in the CNS sometimes survive infection and the effects of infection on neuronal function is largely unknown. To address this question, we used the rJHM strain (rJ) of mouse hepatitis virus (MHV), a neurotropic coronavirus that causes acute encephalitis in susceptible strains of mice. To determine whether neurons or other CNS cells survive acute infection with this virulent virus, we developed a recombinant JHMV that expresses Cre recombinase (rJ-Cre) and infected mice that universally expressed a silent (floxed) version of tdTomato. Infection of these mice with rJ-Cre resulted in expression of tdTomato in host cells. The results showed that some cells were able to survive the infection, as demonstrated by continued tdTomato expression after virus antigen could no longer be detected. Most notably, interneurons in the olfactory bulb, which are known to be inhibitory, represented a large fraction of the surviving cells. In conclusion, our results indicated that some neurons are resistant to virus-mediated cell death and provide a framework for studying the effects of prior coronavirus infection on neuron function.IMPORTANCE We developed a novel recombinant virus that allows the study of cells that survive an infection by a central nervous system-specific strain of murine coronavirus. Using this virus, we identified neurons and, to a lesser extent, nonneuronal cells in the brain that were infected during the acute phase of the infection and survived for approximately 2 weeks until the mice succumbed to the infection. We focused on neurons and glial cells within the olfactory bulb because the virus enters the brain at this site. Our results show that interneurons of the olfactory bulb were the primary cell type able to survive infection. Further, these results indicate that this system will be useful for functional and gene expression studies of cells in the brain that survive acute infection.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  coronavirus; encephalitis; interneurons; olfactory bulb

Year:  2017        PMID: 28835503      PMCID: PMC5660484          DOI: 10.1128/JVI.01099-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Analysis of nonessential gene function in recombinant MHV-JHM. Gene 4 knockout recombinant virus.

Authors:  E Ontiveros; L Kuo; P Masters; S Perlman
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

2.  Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS.

Authors:  E Ontiveros; L Kuo; P S Masters; S Perlman
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

Review 3.  The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system.

Authors:  Debby van Riel; Rob Verdijk; Thijs Kuiken
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

4.  Detection of mouse-adapted human influenza virus in the olfactory bulbs of mice within hours after intranasal infection.

Authors:  Jeannine A Majde; Stewart G Bohnet; Georgeann A Ellis; Lynn Churchill; Victor Leyva-Grado; Melissa Wu; Eva Szentirmai; Abdur Rehman; James M Krueger
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

5.  Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo.

Authors:  B D Pearce; M V Hobbs; T S McGraw; M J Buchmeier
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

Review 6.  Origin and function of olfactory bulb interneuron diversity.

Authors:  Pierre-Marie Lledo; Florian T Merkle; Arturo Alvarez-Buylla
Journal:  Trends Neurosci       Date:  2008-07-05       Impact factor: 13.837

Review 7.  Coronaviruses post-SARS: update on replication and pathogenesis.

Authors:  Stanley Perlman; Jason Netland
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

8.  Immune clearance of attenuated rabies virus results in neuronal survival with altered gene expression.

Authors:  Emily A Gomme; Christoph Wirblich; Sankar Addya; Glenn F Rall; Matthias J Schnell
Journal:  PLoS Pathog       Date:  2012-10-11       Impact factor: 6.823

9.  Adult neural stem cells in distinct microdomains generate previously unknown interneuron types.

Authors:  Florian T Merkle; Luis C Fuentealba; Timothy A Sanders; Lorenza Magno; Nicoletta Kessaris; Arturo Alvarez-Buylla
Journal:  Nat Neurosci       Date:  2013-12-22       Impact factor: 24.884

10.  Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures.

Authors:  M E Dubois-Dalcq; E W Doller; M V Haspel; K V Holmes
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

View more
  14 in total

1.  T cell engagement of cross-presenting microglia protects the brain from a nasal virus infection.

Authors:  E Ashley Moseman; Alexa C Blanchard; Debasis Nayak; Dorian B McGavern
Journal:  Sci Immunol       Date:  2020-06-05

2.  Congenital Cytomegalovirus Infection Alters Olfaction Before Hearing Deterioration In Mice.

Authors:  Françoise Lazarini; Lida Katsimpardi; Sarah Levivien; Sébastien Wagner; Pierre Gressens; Natacha Teissier; Pierre-Marie Lledo
Journal:  J Neurosci       Date:  2018-10-19       Impact factor: 6.167

Review 3.  Prevalence and prognosis of otorhinolaryngological symptoms in patients with COVID-19: a systematic review and meta-analysis.

Authors:  Jingjing Qiu; Xin Yang; Limei Liu; Ting Wu; Limei Cui; Yakui Mou; Yan Sun
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-05-25       Impact factor: 2.503

4.  COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.

Authors:  Jesús Porta-Etessam; Iván J Núñez-Gil; Nuria González García; Cristina Fernandez-Perez; María C Viana-Llamas; Charbel Maroun Eid; Rodolfo Romero; María Molina; Aitor Uribarri; Victor Manuel Becerra-Muñoz; Marcos García Aguado; Jia Huang; Elisa Rondano; Enrico Cerrato; Emilio Alfonso; Alex Fernando Castro Mejía; Francisco Marin; Sergio Raposeiras Roubin; Martino Pepe; Gisela Feltes; Paloma Maté; Bernardo Cortese; Luis Buzón; Jorge Játiva Mendez; Vicente Estrada
Journal:  Infection       Date:  2021-03-01       Impact factor: 3.553

5.  Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.

Authors:  Marlene M Speth; Thirza Singer-Cornelius; Michael Oberle; Isabelle Gengler; Steffi J Brockmeier; Ahmad R Sedaghat
Journal:  Otolaryngol Head Neck Surg       Date:  2020-05-19       Impact factor: 3.497

Review 6.  Infectivity of human coronavirus in the brain.

Authors:  Qi Cheng; Yue Yang; Jianqun Gao
Journal:  EBioMedicine       Date:  2020-05-28       Impact factor: 8.143

7.  Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population.

Authors:  Behzad Iravani; Artin Arshamian; Aharon Ravia; Eva Mishor; Kobi Snitz; Sagit Shushan; Yehudah Roth; Ofer Perl; Danielle Honigstein; Reut Weissgross; Shiri Karagach; Gernot Ernst; Masako Okamoto; Zachary Mainen; Erminio Monteleone; Caterina Dinnella; Sara Spinelli; Franklin Mariño-Sánchez; Camille Ferdenzi; Monique Smeets; Kazushige Touhara; Moustafa Bensafi; Thomas Hummel; Noam Sobel; Johan N Lundström
Journal:  Chem Senses       Date:  2020-05-22       Impact factor: 3.160

8.  Non-lytic clearance of influenza B virus from infected cells preserves epithelial barrier function.

Authors:  Rebekah E Dumm; Jessica K Fiege; Barbara M Waring; Chay T Kuo; Ryan A Langlois; Nicholas S Heaton
Journal:  Nat Commun       Date:  2019-02-15       Impact factor: 14.919

Review 9.  Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19.

Authors:  Mahesh Kandasamy
Journal:  Med Drug Discov       Date:  2020-04-29

Review 10.  Neuropathogenic human coronaviruses: A review.

Authors:  Osama S Abdelaziz; Zuraiha Waffa
Journal:  Rev Med Virol       Date:  2020-07-20       Impact factor: 11.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.